COVID-19.рф: ИНФОРМАЦИЯ ПРОТИВ ПАНДЕМИИ

Поиск по репозиторию

Статья

Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

N. Papadopoulos, A. Custovic, A. Deschildre, A. Mathioudakis, W. Phipatanakul, G. Wong, P. Xepapadaki, I. Agache, L. Bacharier, M. Bonini, J. Castro-Rodriguez, Z. Chen, T. Craig, F. Ducharme, Z. El-Sayed, W. Feleszko, A. Fiocchi, L. Garcia-Marcos, J. Gern, A. Goh, R. Gómez, E. Hamelmann, G. Hedlin, E. Hossny, T. Jartti, O. Kalayci, A. Kaplan, J. Konradsen, P. Kuna, S. Lau, S. Le, R. Lemanske, M. Mäkelä, M. Morais-Almeida, C. Murray, K. Nagaraju, L. Namazova-Baranova, A. Garcia, O. Yusuf, P. Pitrez, P. Pohunek, B. Pozo, G. Roberts, A. Valiulis, H. Zar, R. Taam, H. Azuara, J. Brouard, P. Cros, L. De, J. Dubus, T. Dunder, K. Efendieva, C. Egron, A. Emeryk, V. Huerta, N. Karen, R. Le, J. Levina, M. Medley, M. Najaraju, D. Yeverino, M. Ruotsalainen, S. Szefler, C. Schweitzer, B. Benhumea, R. Villarreal, L. Weiss, A. Zawadzka-Krajewska,
2021
https://doi.org/10.1016/j.jaip.2020.06.001

Background: It is unclear whether asthma may affect susceptibility or severity of coronavirus disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic. Objective: To describe the impact of the COVID-19 pandemic on pediatric asthma services and on disease burden in their patients. Methods: An online survey was sent to members of the Pediatric Asthma in Real Life think tank and the World Allergy Organization Pediatric Asthma Committee. It included questions on service provision, disease burden, and the clinical course of confirmed cases of COVID-19 infection among children with asthma. Results: Ninety-one respondents, caring for an estimated population of more than 133,000 children with asthma, completed the survey. COVID-19 significantly impacted pediatric asthma services: 39% ceased physical appointments, 47% stopped accepting new patients, and 75% limited patients' visits. Consultations were almost halved to a median of 20 (interquartile range, 10-25) patients per week. Virtual clinics and helplines were launched in most centers. Better than expected disease control was reported in 20% (10%-40%) of patients, whereas control was negatively affected in only 10% (7.5%-12.5%). Adherence also appeared to increase. Only 15 confirmed cases of COVID-19 were reported among the population; the estimated incidence is not apparently different from the reports of general pediatric cohorts. Conclusions: Children with asthma do not appear to be disproportionately affected by COVID-19. Outcomes may even have improved, possibly through increased adherence and/or reduced exposures. Clinical services have rapidly responded to the pandemic by limiting and replacing physical appointments with virtual encounters. © 2020 American Academy of Allergy, Asthma & Immunology

Цитирование

Похожие публикации

Impact of the covid-19 pandemic on the oncological practice
A. Kaprin, E. Gameeva, A. Polyakov,
ВЛИЯНИЕ ПАНДЕМИИ COVID-19 НА ОНКОЛОГИЧЕСКУЮ ПРАКТИКУ
Каприн А. Д., Гамеева Е. В., Поляков А. А.,
International Impact of COVID-19 on the Diagnosis of Heart Disease
A. Einstein, L. Shaw, C. Hirschfeld,

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • N. Papadopoulos
    Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, United Kingdom
  • A. Custovic
    Allergy Department, 2nd Paediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece
  • A. Deschildre
    Department of Paediatrics, Imperial College London, London, United Kingdom
  • A. Mathioudakis
    Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, Lille, France
  • W. Phipatanakul
    North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
  • G. Wong
    Children's Hospital Boston, Pediatric Allergy and Immunology, Boston, MA, United States
  • P. Xepapadaki
    Department of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong
  • I. Agache
    Allergy & Clinical Immunology, Transylvania University, Brasov, Romania
  • L. Bacharier
    Division of Allergy, Immunology and Pulmonary MedicineDepartment of Pediatrics, Washington University, St Louis, Mo
  • M. Bonini
    Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli – IRCCS, Rome, Italy
  • J. Castro-Rodriguez
    National Heart and Lung Institute (NHLI), Imperial College London, London, United Kingdom
  • Z. Chen
    Division of Pediatrics, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile
  • T. Craig
    Pulmonology Department, Children's Hospital Zhejiang University School of MedicineZhejiang, China
  • F. Ducharme
    Department of Allergy and Immunology, Penn State University, State College, Pa, United States
  • Z. El-Sayed
    Department of Pediatrics, University of Montréal, Department of Social and Preventive Medicine, University of Montréal, Montréal, QC, Canada
  • W. Feleszko
    Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt
  • A. Fiocchi
    Department of Pediatric Respiratory Diseases and Allergy, The Medical University of Warsaw, Warsaw, Poland
  • L. Garcia-Marcos
    Allergy Department, Bambino Gesù Children's Hospital, Rome, Italy
  • J. Gern
    Pediatric Respiratory and Allergy Units, “Virgen de la Arrixaca” Children's University Clinical Hospital, University of Murcia, Murcia, Spain
  • A. Goh
    Institute for Biomedical Research of Murcia, IMIB-Arrixaca, & Network of Asthma and Adverse and Allergic Reactions (ARADyAL), Murcia, Spain
  • R. Gómez
    Department of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis, United States
  • E. Hamelmann
    Department of Internal Medicine, Rush Medical College, Chicago, Ill, United States
  • G. Hedlin
    Research & Education, Ayre Foundation, Salta, Argentina
  • E. Hossny
    Allergy & Asthma Department, Alas Medical Institute, Salta, Argentina
  • T. Jartti
    Children's Center Bethel, EvKB, University Bielefeld, Bielefeld, Germany
  • O. Kalayci
    Paediatric Allergy, Centre for Allergy Research, Karolinska Institutet, Solna, Sweden
  • A. Kaplan
    Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt
  • J. Konradsen
    Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland
  • P. Kuna
    Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey
  • S. Lau
    Family Physician Airways Group of Canada, Edmonton, AB, Canada
  • S. Le
    Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden
  • R. Lemanske
    Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
  • M. Mäkelä
    Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland
  • M. Morais-Almeida
    Charité Universitätsmedizin Berlin, Pediatric Pulmonology, Immunology and Intensive Care Medicine, Berlin, Germany
  • C. Murray
    School of Paediatrics & Child Health, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, WA, Australia
  • K. Nagaraju
    Departments of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis, United States
  • L. Namazova-Baranova
    Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland
  • A. Garcia
    Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal
  • O. Yusuf
    VN Allergy & Asthma Research Centre, Chennai, Tamilnadu, India
  • P. Pitrez
    Pediatric Department, Pirogov Russian National Research Medical University, the Ministry of Health, Moscow, Russian Federation
  • P. Pohunek
    Pediatric Pulmonology & Allergy Unit, Children's Hospital la Fe, Valencia, Spain
  • B. Pozo
    Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom
  • G. Roberts
    Pediatric Pulmonology Division, Hospital Moinhos de Vento, Porto Alegre, Brazil
  • A. Valiulis
    Pediatric Pulmonology, Pediatric Department, 2nd Faculty of Medicine, Charles University, Prague, University Hospital Motol, Prague, Czech Republic
  • H. Zar
    Teaching and Research Department and Paediatric Allergy Department, Hospital with Specialties Juan María de Salvatierra, La Paz, Baja California Sur México, La Paz, Mexico
  • R. Taam
    Allergy & Immunology Department, Hospital Infantil de Medico Federico Gomez, Mexico City, Mexico
  • H. Azuara
    Paediatric Allergy and Respiratory Medicine within Medicine at the University of Southampton, Southampton, United Kingdom
  • J. Brouard
    Clinic of Children's Diseases, Institute of Clinical Medicine, Medical Faculty of Vilnius University, Vilnius, Lithuania
  • P. Cros
    Department of Pediatrics & Child Health, MRC Unit on Child & Adolescent Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa
  • L. De
  • J. Dubus
  • T. Dunder
  • K. Efendieva
  • C. Egron
  • A. Emeryk
  • V. Huerta
  • N. Karen
  • R. Le
  • J. Levina
  • M. Medley
  • M. Najaraju
  • D. Yeverino
  • M. Ruotsalainen
  • S. Szefler
  • C. Schweitzer
  • B. Benhumea
  • R. Villarreal
  • L. Weiss
  • A. Zawadzka-Krajewska
Название журнала
  • Journal of Allergy and Clinical Immunology: In Practice
Том
  • 8
Выпуск
  • 8
Страницы
  • 2592-2599.e3
Ключевые слова
  • Article; asthma; child; cohort analysis; consultation; coronavirus disease 2019; disease burden; disease control; disease course; health care organization; health center; health impact assessment; health service; health survey; hospital management; human; incidence; major clinical study; pandemic; patient compliance; virtual reality; asthma; Betacoronavirus; Coronavirus infection; global health; medication compliance; organization and management; pathophysiology; severity of illness index; telemedicine; time factor; virus pneumonia; Appointments and Schedules; Asthma; Betacoronavirus; Child; Coronavirus Infections; Global Health; Humans; Medication Adherence; Pandemics; Pneumonia, Viral; Severity of Illness Index; Telemedicine; Time Factors
Издатель
  • American Academy of Allergy, Asthma and Immunology
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY-NC-ND
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus
COVID-19.рф: Информация против пандемии

Адрес: 115114, Москва, ул. Летниковская, д. 4, стр.5, офис 2.4
тел.\факс: +7(499)754-99-94, доб. 502
e-mail: covid19@neicon.ru

Проект реализуется с использованием гранта Президента Российской Федерации на развитие гражданского общества, предоставленного Фондом президентских грантов.

Содержимое сайта, если не указано иное, опубликовано в соответствии с лицензией Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная (CC BY 4.0). Права на материалы, переданные партнерами проекта, принадлежат их правообладателям.

© 2025 NEICON